Multicenter, Randomized, Phase II Trial of CI-1033, an Irreversible Pan-ERBB Inhibitor, for Previously Treated Advanced Non–Small-Cell Lung Cancer von JÄNNE, Pasi A, VON PAWEL, Joachim, DASSE, Kathy, SHEERAN, Meredith, BONOMI, Philip D, COHEN, Roger B, CRINO, Lucio, BUTTS, Charles A, OLSON, Steven S, EISEMAN, Irene A, CHIAPPORI, Alberto A, YEAP, Beow Y, LENEHAN, Peter F

Volltext

P3-098: Multicenter, randomized phase II trial of CI–1033, an irreversible pan– erbB inhibitor, for previously treated advanced non–small cell lung cancer von Janne, Pasi A., von Pawel, Joachim, Cohen, Roger B., Crino, Lucio, Butts, Charles A., Olson, Steven S., Eiseman, Irene A., Chiappori, Alberto A., Yeap, Beow Y., Lenehan, Peter F., Dasse, Kathy, Sheeran, Meredith, Bonomi, Philip D.

Volltext